The Post-Traumatic Stress Disorder Market to Grow Positively at a Considerable CAGR During the Study Period (2019–2032), Assesses DelveInsight

Nevada (Las Vegas), United States, DelveInsight’s “Post-Traumatic Stress Disorder – Market Insight, Epidemiology and Market Forecast – 2032” report provides current treatment practices, emerging drugs, Post-Traumatic Stress Disorder market share of the individual therapies, current and forecasted Post-Traumatic Stress Disorder market size from 2019 to 2032 segmented by seven major markets. The report also offers current Post-Traumatic Stress Disorder therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Post-Traumatic Stress Disorder market.

Post-Traumatic Stress Disorder Overview
PTSD is defined as “the complex physical, cognitive, emotional, and behavioral consequences of psychological trauma.” It is characterized by intrusive thoughts, nightmares, flashbacks to past traumatic events, avoidance of traumatic reminders, hypervigilance, and sleep disturbance, all of which contribute to significant social, occupational, and interpersonal dysfunction. Post Traumatic Stress Disorder causes include intense fear, helplessness, and horror.

Symptoms of Post Traumatic Stress Disorder can appear as soon as a month after a stressful event, but they can also appear years later. These symptoms cause significant problems in social and work situations, as well as in relationships. They can also impair one’s ability to perform routine daily tasks. There are four types of Post Traumatic Stress Disorder symptoms: intrusive recollections, avoidance, unfavorable changes in thinking and mood, and changes in physical and emotional reactions. Symptoms can vary over time and between individuals.

The doctor will most likely perform a physical exam to rule out any medical issues that may be causing the symptoms – a psychological evaluation that includes a discussion of the signs and symptoms, as well as the event or events that precipitated them – and will use the criteria from the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).

Post-Traumatic Stress Disorder Epidemiological Insights

The Post-Traumatic Stress Disorder epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by prevalence population, diagnosed prevalent cases, gender-specific cases, severity-specific cases, age-specific cases, total treated cases in the 7MM market covering the United States, EU-4 countries (Germany, France, Italy, Spain), the United Kingdom, and Japan from 2019 to 2032.

As per DelveInsight, the total Post Traumatic Stress Disorder diagnosed 12-month prevalent cases in the 7MM was more than 5 million in 2021. Among the 7MM, the United States has the highest prevalent cases of Post Traumatic Stress Disorder in 2021.

Post-Traumatic Stress Disorder Treatment Market
Patients with Post Traumatic Stress Disorder are treated using a multidimensional strategy. Treatment options include patient education, social support, and anxiety management via psychotherapy and psychopharmacological intervention. Patient education and social support are essential early interventions for engaging the patient and reducing the impact of the traumatic experience.

There are many different types of psychotherapy, also known as talk therapy, that can be used to treat PTSD in children and adults. Psychotherapy techniques used in the treatment of Post Traumatic Stress Disorder include cognitive therapy, exposure therapy, eye movement desensitization (EMDR), and reprocessing.

Promising Therapies in the Post-Traumatic Stress Disorder Pipeline
• JZP150,
• NYX-783
• Rexulti (brexpiprazole) and Zoloft (sertraline) combination
• BNC210

Discover more about Post-Traumatic Stress Disorder therapies in the pipeline @ Post-Traumatic Stress Disorder Drugs

Leading Companies Working in the Post-Traumatic Stress Disorder Market
• Jazz Pharmaceuticals
• Aptinyx
• Otsuka Pharmaceutical Development & Commercialization, Inc.
• Bionomics Limited
• Nobilis Therapeutics
• H. Lundbeck A/S
• Boehringer Ingelheim
• AstraZeneca
• Remedy
• Pfizer
• Tonix Pharmaceuticals, Inc.

Learn more about the recent developments and breakthroughs in the Post-Traumatic Stress Disorder market @ Post-Traumatic Stress Disorder Clinical Trials

Post-Traumatic Stress Disorder Market Dynamics
The introduction of novel drugs and classes of new therapeutic drugs for treatment into the Post Traumatic Stress Disorder market will provide hope to PTSD patients and may have a significant positive impact on the Post Traumatic Stress Disorder market. Furthermore, new diagnostic categories based on PTSD have been proposed, including Prolonged Duress Stress Disorder, Post-Traumatic Mourning Disorder, Post-Traumatic Relationship Syndrome, Post-Traumatic Dental Care Anxiety, and Post-Traumatic Abortion Syndrome, which will all help to boost the Post Traumatic Stress Disorder market.

As per DelveInsight analysis, the Post Traumatic Stress Disorder market size was over USD 1,740.2 billion in 2021, which is further expected to increase by 2032.

However, certain factors are limiting the Post Traumatic Stress Disorder market’s growth. The main disadvantage of PTSD is that it is associated with high rates of comorbidities, psychiatric and medical diseases, as well as alcohol and drug abuse, resulting in poor QOL and physical health, impeding the Post Traumatic Stress Disorder market’s growth.

Scope of the Post-Traumatic Stress Disorder Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, Japan]
Key Post-Traumatic Stress Disorder Companies: Jazz Pharmaceuticals, Aptinyx, Otsuka Pharmaceutical Development & Commercialization, Inc., Bionomics Limited, Nobilis Therapeutics,H. Lundbeck A/S, Boehringer Ingelheim, AstraZeneca, Remedy, Pfizer, Tonix Pharmaceuticals, Inc., and others
Key Post-Traumatic Stress Disorder Pipeline Therapies: JZP150, NYX-783, Rexulti (brexpiprazole) and Zoloft (sertraline) combination, BNC210, and others, and others
Therapeutic Assessment: Post-Traumatic Stress Disorder current marketed and emerging therapies
Post-Traumatic Stress Disorder Market Dynamics: Post-Traumatic Stress Disorder market drivers and barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Unmet Needs, KOL’s views, Analyst’s views, Post-Traumatic Stress Disorder Market Access and Reimbursement

Table of Contents
1. Post-Traumatic Stress Disorder Market Key Insights
2. Post-Traumatic Stress Disorder Market Report Introduction
3. Post-Traumatic Stress Disorder Market Overview at a Glance
4. Post-Traumatic Stress Disorder Market Executive Summary
5. Disease Background and Overview
6. Post-Traumatic Stress Disorder Treatment and Management
7. Post-Traumatic Stress Disorder Epidemiology and Patient Population
8. Patient Journey
9. Post-Traumatic Stress Disorder Emerging Drugs
10. 7MM Post-Traumatic Stress Disorder Market Analysis
11. Post-Traumatic Stress Disorder Market Outlook
12. Potential of Current and Emerging Therapies
13. KOL Views
14. Post-Traumatic Stress Disorder Market Drivers
15. Post-Traumatic Stress Disorder Market Barriers
16. Unmet Needs
17. SWOT Analysis
18. Appendix
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Us
Sandeep Joshi
info@delveinsight.com
+1(919)321-6187